QuickTip #7: Improve purity of viruses and vaccines
Changing from purification products based on synthetic polymers to agarose-based chromatography will increase the purity [...]
Enhanced Capture Process – a presentation
Just before the Christmas break, Lars, Haneskog, Bio-Works R&D Director, presented a new and proven [...]
Quarterly report Q1 2019
Bio-Works Technologies AB Quarterly report Q1 2019 Period 1 January – 31 March 2019 in [...]
Investment presentation at BioStock
Mats Johnson, CEO of Bio-Works will be presenting for investors at the BioStock live STHLM [...]
Interview with Dr. Yong Chul Shin, CEO of Amicogen Inc.
Amicogen Inc. is the largest shareholder in Bio-Works Technologies AB as of today, with slighty [...]
Bokslutskommuniké Januari – december 2018
Pressmeddelande 22 februari 2019 kl. 12:00 […]
Bio-Works VD och Styrelseordförande på intervju hos Vator
I detta avsnitt av Vatorpodden intervjuas Bio-Works VD Mats Johnson och styrelseordförande Thomas Pollare. De [...]
WorkBeads used for full scale production of FDA approved drug
Press release April 12, 2018 Bio-Works’ separation media, WorkBeads, has become standard for the production [...]
Bio-Works secures another order from PolyPeptide
Press release Februari 23 2018 Bio-Works has received an order of 1,0 million SEK from [...]
Bio-Works säkrar ytterligare en order från PolyPeptide
Pressmeddelande den 23 februari 2018, kl: 07:37 Bio-Works har erhållit en order värd 1,0 miljon [...]
